Navigation Links
Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
Date:4/27/2010

THE WOODLANDS, Texas, April 27 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana. Results from the study, in which LX1031 produced improvements in IBS symptoms, will be presented during the poster session on Sunday, May 2, 2010 from 12 p.m. to 2 p.m. Central Time and the oral presentation on Wednesday, May 5, 2010 at 9:30 a.m. CT (session start time is 8:30 a.m. CT).

DDW is the world's largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Every year it attracts approximately 16,000 physicians, researchers and academics from around the world.

Clinical development of LX1031 is being funded through a product development
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Announces Proposed $95 Million Common Stock Offering
2. Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
3. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
4. Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
5. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
6. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
7. Lexicon Announces Completion of Public Offering of Common Stock
8. Lexicon Announces Pricing of Common Stock in Public Offering
9. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
10. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is investigating ... ("Vitae" or the "Company") (NASDAQ: VTAE ).  ... Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. ... certain of its officers and/or directors have violated Sections ... 1934.  On February 27, 2015, the ...
(Date:2/27/2015)... 2015  Following a bipartisan vote in the ... 284, the Medicare DMEPOS Competitive Bidding Improvement Act ... (AAHomecare) released a statement praising the Committee,s work ... legislation. "Today,s mark-up of the Competitive ... Means Committee is a critical step forward for ...
(Date:2/27/2015)... -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... net operating loss (NOL) guidance and its cash guidance ... significantly improved financial results were due in large part ... Company received from its partners.  Isis, pro forma NOL ... improvement over its 2013 NOL of $40.2 million. On ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... 2011 InspireMD , developer ... has expanded its MGuard production facilities to meet the ... accelerating demand for MGuard include the recent recommendation of ... be considered for PCI of highly thrombotic or SVG ...
... March 2, 2011 InstaCare Corp. (OTC Bulletin Board: ... and non-prescription diagnostics, home testing products for the chronically ... diabetes programs, and a leading developer of revolutionary cell ... company,s Board of Directors has received a patent and ...
Cached Medicine Technology:InspireMD Boosts MGuard Production Capacity 2InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA 2InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA 3
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. ... recently featured in the January/February 2015 issue of Elevate ... Ellis was featured in an article entitled “Get the ... that Kim Cattrall has possibly undergone to maintain her ... smooth without horizontal lines or frown line creases, which ...
(Date:2/28/2015)... 28, 2015 Javon Bea Mercy ... Harvard Hospital as stroke capable by the State of ... ambulance to Mercy Harvard Hospital. , The hospital was ... their ability to treat stroke according to national standards ... transporting stroke patients to bypass hospitals not designated as ...
(Date:2/28/2015)... Plugin creators from Pixel Film Studios ... fully customizable transition pack made specifically for ... users total control over 30 transition presets built exclusively ... Film Studios. “TransFold Volume 2 gives endless possibilities to ... 2 from Pixel Film Studios brings back folding screen ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The World ... and learning materials to potential EMTs and firefighters, recently ... Bitcoins as a way to raise charitable donations for ... in Medellin, Columbia, will be held on March 29, ... run will begin at 3:30 p.m. , To ...
(Date:2/28/2015)... 2015 1Heart Caregiver Services CEO ... brand at Houston Texas Franchise Expo South and ... its executive delegates headed by Vice-President of Operations ... Training Randolph Clarito. , Franchise Expo South, sponsored ... February 4-7 and featured Franchise brands of every ...
Breaking Medicine News(10 mins):Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3
... (HealthDay News) -- Children born to mothers with postpartum depression ... hormone called oxytocin may reduce the risk, according to a ... body and has been associated with feelings of love and ... maternal depression, the researchers found. A synthetic version of the ...
... HealthDay Reporter , FRIDAY, Dec. 9 (HealthDay News) ... more form of entertainment. But for Katie Sweeney and her ... celebration. "It was absolute redemption," said Sweeney, recalling the ... Dylan, and 14-year-old son Dusty -- who has autism -- ...
... Centre for Reviews and Dissemination (CRD) at the University ... Health is a new online service provided by the ... National Library of Medicine (NLM) the world,s largest ... of selected systematic reviews and also provides information for ...
... GREENVILLE, S.C. From their fourth-floor state-of-the-art laboratory in ... University bioengineering scientists and students help keep the feet ... new facility, which opens this week, houses one of ... hip, knee and other artificial joints that were removed ...
... mobility of registered nurses (RNs) recently published in the December ... lack of mobility has serious implications for access to health ... studypart of the RN Work Project funded by the Robert ... RNs work within 40 miles of where they attended high ...
... a certain form of inherited hearing loss have ... a study by Professor Thomas Jentsch of the ... Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin ... Spain and Nijmegen, the Netherlands. The research findings, ...
Cached Medicine News:Health News:'Love Hormone' May Buffer Kids From Mom's Depression 2Health News:Broadway Strikes an Autism-Friendly Chord 2Health News:Broadway Strikes an Autism-Friendly Chord 3Health News:Broadway Strikes an Autism-Friendly Chord 4Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 2Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 3Health News:New registered nurses' lack of geographic mobility has negative implications for rural health 2Health News:New registered nurses' lack of geographic mobility has negative implications for rural health 3Health News:People with DFNA2 hearing loss show increased touch sensitivity 2Health News:People with DFNA2 hearing loss show increased touch sensitivity 3
Alexander periosteal elevators....
Sedillot periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Steinhauser periosteal elevator....
Medicine Products: